HR 3320
98th Congress
House
A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 17, 1983
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Jun 15, 1983
Referred to House Committee on The Judiciary.
Jun 15, 1983
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to Subcommittee on Courts, Civil Liberties, and the Administration of Justice.
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 3320: A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.. 98th Congress. Open America. https://openamerica.io/bill/98-HR-3320/
"H.R. 3320: A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.." 98th Congress, 2026, Open America, https://openamerica.io/bill/98-HR-3320/.
H.R. 3320, 98th Cong. (2026), https://openamerica.io/bill/98-HR-3320/.
[H.R. 3320: A bill to provide that the trademark law does not require that each drug be manufactured in a tablet which is unique as to its size, color, and shape.](https://openamerica.io/bill/98-HR-3320/)